Direktorat Registrasi ObatValid

VIRIDIS

BPOM Number: DKL1121641010A1
Approved: 24 June 2026
Expiry: 1 April 2031
Form: Tablet

About This Registration

VIRIDIS is a BPOM-registered direktorat registrasi obat in Indonesia, registered under number DKL1121641010A1. Its current registration status is Valid, with the licence valid until 1 April 2031. The product is registered to PHAROS INDONESIA - INDONESIA. BPOM first approved this registration in May 2026. All registration data is sourced directly from the official BPOM public database and updated daily.

Registration data updated by BPOM

This product's registration details were changed on 1 July 2026. This may reflect a status change, renewal, or correction by BPOM.

Registration Details

Application: newaero
Packaging: DUS, 1 BLISTER @ 10 TABLET
Department: Direktorat Registrasi Obat
Data Last Updated: 1 July 2026

Retail Audit Service

Get detailed market intelligence for this product across Indonesian retail channels

Multiple cities available

Custom questionnaires

Professional shoppers

Detailed reporting

Starting from $50 per city

What's included in the audit service?

Stock availability and positioning verification

Price checking and competitor analysis

Display quality and promotional material assessment

Store condition and customer experience evaluation

Custom questions tailored to your research needs

Professional photographs and detailed reports

Registered Owners

PHAROS INDONESIA - INDONESIA
KODYA JAKARTA SELATAN
NPWP: 12345678910
owner
View profile →

Manufacturing Sites

PHAROS INDONESIA - INDONESIA
KODYA JAKARTA SELATAN
primary
View profile →

Ingredients (1)

METHISOPRINOL

Market Intelligence

Owner Portfolio: PHAROS INDONESIA - INDONESIA holds 177 BPOM registrations
Manufacturer Scale: PHAROS INDONESIA - INDONESIA produces 177 registered products
Registration Age: Registered for 3 months
Update Status: Recently updated (69 days ago)

FDA Cross-Reference

via openFDA

Generic Name: ALNUS VIRIDIS SUBSP. CRISPA LEAF
Product Type: HUMAN OTC DRUG
Route of Administration: SUBLINGUAL
Purpose: Support for the uterus and veins.

Data sourced from the U.S. FDA drug label database (openFDA). May not exactly match this product variant.

Is this your product?